Clinicopathological spectrum of pediatric renaldiseases: a single-center experience based on nativekidney biopsies
Abstract
Background: In pediatric renal disorders, the decision about further evaluation, the choice of treatment, and prognosis depends upon the histopathological pattern of injury. The study is done to characterize the indications and renal histopathological spectrum of kidney diseases among children who underwent kidney biopsy. Methods: This is a single-center, retrospective, cross-sectional study. The data of the Children aged ≤18 years who underwent a kidney biopsy in the Department of Nephrology from January 2022 to August 2024 were retrieved from the hospital records and analyzed. Results: Out of 601 biopsies, pediatric biopsies accounted for 61/601 (10.1%) of all biopsies. The most common indication for kidney biopsy was nephrotic syndrome, present in 39/61 (63.9%), followed by nephritic syndrome and asymptomatic urinary abnormality, present in 9/61 (14.8%), and 5/61 (8.2%), respectively. The most common renal histopathological lesion was minimal change disease in 18/61 (29.5%), followed by focal segmental glomerulosclerosis (FSGS) and IgA (Immunoglobin A) nephropathy present in 12/61 (19.7%) and 8/61 (13.1%), respectively. Minimal change disease, FSGS, and IgA nephropathy accounted for 18/39 (46.2%), 10/39 (25.6%), and 5/39 (12.8%) of all cases of nephrotic syndrome. IgA and lupus nephritis each accounted for 3/9 (33.3%) of nephritic syndrome patients. FSGS NOS (Not otherwise specified) variant accounted for 10/12 (83.3%) of FSGS cases. Diffuse foot process effacement was observed in 66.7% of FSGS cases, with 10/12 (83.3%) presenting with nephrotic syndrome. Among IgA with a nephrotic presentation, 60% showed diffuse foot process effacement. Conclusions: In pediatric nephrology, nephrotic syndrome stands as the leading indication for kidney biopsy, with minimal change disease, FSGS, and IgA nephropathy comprising the majority of diagnoses. Electron microscopy is a crucial diagnostic tool, particularly in differentiating primary podocytopathies.